Akèy › Anplwayè › Canaccord Genuity LLC
Canaccord Genuity LLC: Salè H-1B ak pajon
Canaccord Genuity LLC depoze 22 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 22. Medyèn salè yo ofri a: $135,000.
Èske Canaccord Genuity LLC pajone visa H-1B?
Canaccord Genuity LLC depoze 22 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 13, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Investment Banking Analyst | 3 | $100,000 |
| Associate, Australian Desk Salesperson | 2 | $110,000 |
| Banking Analyst 1 | 2 | $100,000 |
| Director, Investment Banking | 1 | $250,000 |
| Senior Research Associate (Biotechnology) | 1 | $135,000 |
| Analyst (2nd Year) | 1 | $105,000 |
| Analyst (3rd Year) | 1 | $120,000 |
| Director, Australian Equities | 1 | $175,000 |
| Director, Salesperson | 1 | $120,000 |
| Vice President - Australian Product Sales | 1 | $145,000 |
| Australian Institutional Equity Sales (Americas) | 1 | $188,880 |
| Banking Analyst 2 | 1 | $110,000 |
| Second Year Banking Associate | 1 | $180,000 |
| Vice President, Biotechnology Equity Research | 1 | $150,000 |
| Managing Director, Australian Equity Sales Manager | 1 | $175,000 |
| Managing Director, Australian Equity Sales - Americas | 1 | $175,000 |
| Investment Banking Associate 2 | 1 | $180,000 |
| VP, Biotechnology Equity Research | 1 | $150,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 9 | $110,000 |
| FY2024 | 2 | $147,500 |
| FY2025 | 7 | $145,000 |
| FY2026 | 4 | $175,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Financial and Investment Analysts10
- Securities, Commodities, and Financial Services Sales Agents8
- Statisticians3
- Financial Managers1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| VP, Biotechnology Equity Research | $150,000 Nivo III | New York, NY | May 13, 2026 | Oct 1, 2026 | Certifye |
| Investment Banking Associate 2 | $180,000 Nivo IV | New York, NY | Apr 21, 2026 | Oct 1, 2026 | Certifye |
| Managing Director, Australian Equity Sales - Americas | $175,000 Nivo II | New York, NY | Apr 21, 2026 | Oct 1, 2026 | Certifye |
| Managing Director, Australian Equity Sales Manager | $175,000 E-3 · Nivo II | New York, NY | Nov 5, 2025 | Dec 1, 2025 | Certifye |
| Second Year Banking Associate | $180,000 Nivo III | New York, NY | Aug 19, 2025 | Sep 8, 2025 | Certifye |
| Vice President, Biotechnology Equity Research | $150,000 Nivo III | New York, NY | Jul 8, 2025 | Oct 1, 2025 | Certifye |
| Banking Analyst 1 | $100,000 Nivo I | New York, NY | Apr 8, 2025 | Oct 1, 2025 | Certifye |
| Banking Analyst 1 | $100,000 Nivo I | New York, NY | Apr 8, 2025 | Oct 1, 2025 | Certifye, apre retire |
| Banking Analyst 2 | $110,000 Nivo I | New York, NY | Apr 8, 2025 | Oct 1, 2025 | Certifye |
| Australian Institutional Equity Sales (Americas) | $188,880 E-3 · Nivo II | New York, NY | Jan 8, 2025 | Mar 1, 2025 | Certifye |
| Vice President - Australian Product Sales | $145,000 E-3 · Nivo II | New York, NY | Sep 26, 2024 | Dec 1, 2024 | Certifye |
| Director, Australian Equities | $175,000 E-3 · Nivo III | New York, NY | Sep 26, 2023 | Dec 1, 2023 | Certifye |
| Director, Salesperson | $120,000 H-1B1 (Chili) · Nivo III | Miami, FL | Sep 26, 2023 | Dec 1, 2023 | Certifye |
| Senior Research Associate (Biotechnology) | $135,000 Nivo III | New York, NY | Jun 12, 2023 | Aug 31, 2023 | Certifye |
| Investment Banking Analyst | $100,000 Nivo I | New York, NY | Mar 20, 2023 | Sep 2, 2023 | Certifye, apre retire |
| Investment Banking Analyst | $135,000 Nivo I | New York, NY | Mar 16, 2023 | Aug 23, 2023 | Certifye |
| Investment Banking Analyst | $100,000 Nivo I | New York, NY | Mar 7, 2023 | Aug 20, 2023 | Certifye, apre retire |
| Associate, Australian Desk Salesperson | $110,000 E-3 · Nivo I | New York, NY | Mar 6, 2023 | Apr 1, 2023 | Certifye |
| Associate, Australian Desk Salesperson | $110,000 Nivo I | New York, NY | Mar 6, 2023 | Aug 20, 2023 | Certifye |
| Analyst (3rd Year) | $120,000 Nivo II | New York, NY | May 6, 2022 | May 31, 2022 | Certifye, apre retire |
| Director, Investment Banking | $250,000 Nivo II | New York, NY | Mar 3, 2022 | Jun 1, 2022 | Certifye, apre retire |
| Analyst (2nd Year) | $105,000 Nivo II | Boston, MA | Nov 5, 2021 | Nov 29, 2021 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).